Blood diagnostic biomarkers for neurologic manifestations of long COVID
C5a, TGFβ1, Gliomedin expressed highly in serum could be developed as a diagnostic tool, and with clinical assessment used to personalize treatments with repurposed novel drugs.
Authors
- Robert Kirk DeLisle
- George Tachas
- Igor Jerome Koralnik (ORCID: https://orcid.org/0000-0001-6836-1468)
- Lavanya Visvabharathy (ORCID: https://orcid.org/0000-0002-8157-4385)
- Advait Suchet Padhye
- Barbara A. Hanson
Institutions
- Northwestern University (US)
- The Medical Center of Aurora (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Chevron (Australia) (AU)
Publication Details
- Journal
- Brain Behavior & Immunity - Health
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1016/j.bbih.2025.101110
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.39